Reasons Why You Should Hold Docusign Stock in Your Portfolio Now
Werte in diesem Artikel
Docusign, Inc. DOCU has had an impressive run over the past year. Its shares have rallied 41.6%, outperforming the 9.3% rise of the internet software industry and the 10.2% growth of the Zacks S&P 500 composite.Image Source: Zacks Investment ResearchDOCU has an impressive Growth Score of B. This style score condenses all the essential metrics from the company’s financial statements to get the true sense of the quality and sustainability of its growth.The company’s earnings for fiscal 2026 and 2027 are expected to improve by 18.5% and 3.7%, respectively, year over year. DOCU has a long-term (three to five years) expected earnings growth rate of 9.4%.Factors That Augur Well for DOCUDocuSign's Notary On-Demand solution reflects a revolutionary shift in how notarization is handled, offering 24/7 remote access to notaries across all 50 U.S. states. This service addresses the delays and inefficiencies of traditional in-person notarizations, helping businesses streamline critical processes like real estate deals and loan closings.Integrating advanced identity verification tools and secure video technology also helps mitigate fraud risks. The solution’s seamless integration with DocuSign’s eSignature platform and its support for various document types further enhance its utility. Overall, it offers a modern, efficient and secure approach to notarization, which could greatly impact industries that rely on these services.DocuSign's tech-savvy initiatives are commendable, particularly with the launch of Docusign for Developers, which enhances its Intelligent Agreement Management platform. This suite of tools empowers developers to integrate, automate and scale solutions across the agreement lifecycle, offering features like the Maestro and Navigator APIs for custom workflows and data insights.Moreover, AI-Assisted Review simplifies contract reviews by flagging discrepancies and suggesting changes in real time within Microsoft Word. Integrations with Workday, SAP and Salesforce automate data entry and improve accuracy across industries like finance, healthcare and legal services.The company’s shareholder-friendly initiatives are also encouraging as it has a brief history of repurchasing common stock. In fiscal 2023, 2024 and 2025, the company had repurchased common stock worth $63.04 million, $145.5 million and $683.5 million, respectively. In June 2024, DOCU’s decision to increase its stock repurchase program by $1.0 billion reflects confidence in its financial strength and offers value to shareholders. The program’s flexibility, with no set minimum or end date, allows Docusign to adapt to market conditions and investment opportunities.DOCU: Key Risks to WatchDocuSign is facing challenges with high operating expenses, largely due to significant sales and marketing costs. While expenses slightly decreased in fiscal 2024, they remain elevated. In the fourth quarter of fiscal 2024, operating expenses increased by 6.2% year over year, highlighting ongoing pressure in controlling costs despite efforts to reduce them.DOCU's Zacks RankDocusign currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.Stocks to ConsiderSome better-ranked stocks from the broader Zacks Business Services sector are Maximus MMS and Charles River Associates CRAI.Maximus sports a Zacks Rank of 1 (Strong Buy) at present.MMS has an encouraging earnings surprise history, having outpaced the Zacks Consensus estimate in three of the trailing four quarters and missed once. The average beat being 13.3%.Charles River Associates currently carries a Zacks Rank #2 (Buy).CRAI has an encouraging earnings surprise history, having outpaced the Zacks Consensus estimate in each of the trailing four quarters. The average beat being 25.9%.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Charles River Associates (CRAI): Free Stock Analysis Report Maximus, Inc. (MMS): Free Stock Analysis Report Docusign Inc. (DOCU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: DocuSign und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf DocuSign
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DocuSign
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu DocuSign Inc Registered Shs
Analysen zu DocuSign Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
13.02.2019 | DocuSign Buy | Deutsche Bank AG | |
19.10.2018 | DocuSign Neutral | Wedbush Morgan Securities Inc. | |
22.05.2018 | DocuSign Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
13.02.2019 | DocuSign Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
19.10.2018 | DocuSign Neutral | Wedbush Morgan Securities Inc. | |
22.05.2018 | DocuSign Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DocuSign Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen